Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy
Authors
Keywords
-
Journal
EJNMMI Research
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-02
DOI
10.1186/s13550-022-00880-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy
- (2021) Fiona Ohlendorf et al. Diagnostics
- Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
- (2020) Jonathan Strosberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study
- (2020) Arthur J A T Braat et al. LANCET ONCOLOGY
- Lymphocytes and Neutrophil-to-Lymphocyte Ratio Variations After Selective Internal Radiation Treatment for HCC: A Retrospective Cohort Study
- (2020) Florian Estrade et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity
- (2019) A. J. A. T. Braat et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Letter to the editor: The Inflammation-Based Index Can Predict Response and Improve Patient Selection in NETs Treated With PRRT: A Pilot Study
- (2019) Johannes Hofland et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of preoperative monocyte‐to‐lymphocyte and neutrophil‐to‐lymphocyte ratio with recurrence‐free and overall survival after resection of pancreatic neuroendocrine tumors (US‐NETSG)
- (2019) Roheena Z. Panni et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic significance of neutrophil–lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages
- (2019) Norifumi Harimoto et al. PANCREATOLOGY
- Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)
- (2018) Arthur J. A. T. Braat et al. BMC GASTROENTEROLOGY
- The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients
- (2018) Ryoichi Miyamoto et al. EJSO
- Neutrophil lymphocyte ratio and transarterial chemoembolization in neuroendocrine tumor metastases
- (2018) Sean M. McDermott et al. JOURNAL OF SURGICAL RESEARCH
- The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis
- (2018) Yunjiao Wang et al. International Journal of Surgery
- The inflammation-based index can predict response and improve patient selection in NETs treated with PRRT: a pilot study
- (2018) James R M Black et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of Radioembolization with166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study
- (2017) Jip F. Prince et al. JOURNAL OF NUCLEAR MEDICINE
- The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review
- (2017) Abdelhamed Haram et al. JOURNAL OF SURGICAL ONCOLOGY
- Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis
- (2017) Randy C. Bowen et al. Oncotarget
- Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis
- (2015) Hariruk Yodying et al. ANNALS OF SURGICAL ONCOLOGY
- Radioembolization Dosimetry: The Road Ahead
- (2014) Maarten L. J. Smits et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Cancer-Related Inflammation
- (2012) Juliana Candido et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)
- (2012) David J. Pinato et al. JOURNAL OF HEPATOLOGY
- Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
- (2012) Maarten LJ Smits et al. LANCET ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Lymphocytic Toxicity in Patients After Peptide-Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC
- (2009) Maribel L. Sierra et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started